Financial & competing interests disclosure
The author is the Director General of the Association of the British Pharmaceutical Industry (ABPI). The ABPI is the trade association for the UK research-based pharmaceutical industry, representing companies both small and large. Member companies research, develop, manufacture and supply more than 80% of the medicines prescribed through the National Health Service (NHS).
No writing assistance was utilized in the production of this manuscript.